Hexagon Nutrition IPO: Nutraceutical Company Fixes Price Band For Public Issue - Should You Apply?

Hexagon Nutrition is set to launch its public issue on June 5, 2026. The bidding window for Hexagon Nutrition’s initial public offering (IPO) is scheduled to close on June 9, 2026.

Ahead of the opening of the subscription window, the company has announced the price band for its public issue. Here’s a look at some key details related to the company’s public issue, which investors should know before applying:

Hexagon Nutrition IPO Price Band and Lot Size

The Hexagon Nutrition IPO price band has been set at Rs 42 to Rs 45 per share. The minimum lot size to apply for the Hexagon Nutrition IPO for retail investors has been set at 1 lot consisting of 333 shares aggregating to a minimum investment of Rs 14,985.

Hexagon Nutrition IPO: Offer Size, Allotment Date, Listing Date

Hexagon Nutrition IPO plans to raise Rs 138.87 crore at the upper end of the price band. The nutraceutical company’s public issue consists entirely of an offer for sale (OFS) of up to 30.86 million shares by existing promoters.

The basis of allotment for the Hexagon Nutrition IPO is expected to be determined on June 10. Once the share allotment status of the Hexagon Nutrition IPO is decided, successful bidders will receive shares of the Hexagon Nutrition IPO in their demat accounts on June 11. Hexagon Nutrition IPO shares are slated to list on the BSE and NSE. Hexagon Nutrition’s shares will  tentatively list on the exchanges on  June 12.

Hexagon Nutrition IPO: Key Financials

As per the company’s Red Herring Prospectus (RHP), the nutraceutical company’s total income for the financial year ended March 31, 2025, stood at Rs 331.28 crore, up by 8 per cent from Rs 304.62 crore in FY24. The company posted a net profit after tax (PAT) of Rs 24.38 crore for FY 2024-25, indicating a 100 per cent increase from Rs 12.21 crore in FY 2023-24.

Hexagon Nutrition: Business Model

Hexagon Nutrition is a nutrition company which manufactures clinical and nutraceutical products. The company’s product portfolio comprises branded wellness and clinical nutrition products along with customised industrial vitamin and mineral premix formulation. The company also makes Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs).

Hexagon Nutrition: Competitors

The company competes with FMCG conglomerates, clinical health suppliers, and food ingredient developers. The company does not have a direct listed peer which mirrors its exact product mix. However, its broader public peers include Zydus Wellness and Nestle India, according to the RHP.

Hexagon Nutrition IPO: Should You Apply?

Here’s a look at the strengths and risks mentioned by the nutraceutical maker in its RHP, which investors must consider before applying for the public issue:

Hexagon Nutrition: Key Risks

• Hexagon Nutrition earns a major portion of its revenue from the premix formulation segment and relies on key customers within this business line. Thus, any drop in order volumes from these clients can adversely affect the company’s business.

• The company added that it does not have long-term legal contracts with its third-party raw material suppliers, thus its operating margins  are vulnerable to sudden shortfalls.

• The company said its historical capacity utilisation of its manufacturing facilities remains relatively low, according to the RHP.

Hexagon Nutrition: Key Strengths

• The company claims to have end-to-end wellness capabilities supported by a pan-India omnichannel distribution.

• The company holds a strong market presence in the domestic clinical health space through brands like Pentasure, Obesigo, and Pediagold.

• The firm claims to have dedicated in-house R&D centres focused on product innovation.

Hexagon Nutrition IPO: Objective

Hexagon Nutrition will not receive any proceeds from this issue. The entire capital raised will go directly to the respective selling promoters and shareholders. However, the nutraceutical maker intends to enhance its corporate visibility through the public issue.